Objectives: This study tested the hypothesis that longer duration of any type of respiratory support is associated with an increased rate of death or neurodevelopmental impairment (NDI) at 18-22 months.
support group, both invasive [OR 62.7 (95%CI 25.7, 152.6) ] and mixed [OR 6.1 (95%CI 2.6, 14.4) ] support groups were significantly more likely to die or have NDI.
Conclusion: Prolonged respiratory support, whether invasive or non-invasive, is associated with increased odds of a poor outcome. The proportion of infants with a poor outcome increased in a dose dependent manner by two factors: the cumulative duration of respiratory support beyond 60 days, and the extent to which invasive support is provided.
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| INTRODUCTION
Over the past three decades, the survival rate of extremely low birth weight (ELBW, BW < 1000 g) infants with immature lung development has improved. 1, 2 Disappointingly, the outcomes in survivors have not changed significantly. 3, 4 Such ELBW infants often require prolonged ventilation support. Recognition of the hazards of prolonged mechanical ventilation has resulted in increased use of non-invasive respiratory support (NI-RS) modalities. These non-invasive modalities include Nasal Intermittent Positive Pressure Ventilation (NIPPV), Nasal
Continuous Positive Airway Pressure (NCPAP), and High Flow Nasal Cannula (HFNC). [5] [6] [7] [8] [9] [10] [11] Each of these may be used as first line respiratory support, or immediately following mechanical ventilation. Application of these non-invasive modalities can prevent application of invasive support, but may be needed for prolonged periods of time. 12, 13 In an earlier era (1995) (1996) (1997) (1998) , when invasive respiratory support (I-RS) dominated the course of an ELBW infant's time in the newborn intensive care unit (NICU), Walsh et al 14 showed a dose-dependent relationship between the duration of invasive ventilation and both inhospital mortality and 24-month neurodevelopmental disability. It is still unclear, however, whether reducing the duration of I-RS, through aggressive use of NI-RS, avoids or reduces similar adverse outcomes.
Our objective was to assess the hypothesis that increasing duration of any RS is associated with increased death or adverse neurodevelopmental outcomes in survivors at 18-22 months.
| METHOD
This retrospective multi-site study evaluated prospectively collected data from the NICHD Neonatal Research Network (NRN) Generic 
| Secondary 0utcomes
The individual components of the primary outcome (death and NDI) are examined as secondary outcomes. Mild cognitive delay was also analyzed as a secondary outcome, being a BSID-III score <85 (one standard deviation below the mean). In addition, in-hospital morbidity outcomes were examined. These included: late-onset sepsis (positive blood culture at ≥72 h of age), grade III or IV intraventricular hemorrhage (IVH), cystic periventricular leukomalacia (PVL), postnatal steroid exposure, and necrotizing enterocolitis (NEC, modified Bells criteria, stage 2 or 3).
| Statistical analysis
The primary outcome assessed was a composite of death or NDI at 18-22 month corrected age. All outcomes were analyzed for differences between respiratory groups in the total cohort. Ongoing need for I-RS and NI-RS (or duration) was expressed as mean, median, and inter-quartile range. Separate descriptive analyses were performed for each interval assessed (1, 7, 14, 28, 60, 90, 120 days Since all infants diagnosed with BPD required a period of respiratory support, we will not be able to cleanly separate out the effects of respiratory support from the effects of BPD.
Therefore, BPD was not included in the analysis to avoid the confounding effect. Birth weight and maternal factors (age and education) were also included to minimize selection bias due to lost to follow-up. To test if longer duration of support is associated with increased death or NDI, the Mantel-Haenszel Chi-Square Test and Cochran-Armitage Trend Tests were performed.
Additionally, we performed the logistic regression analysis via multiple imputation of the missing data. The method of fully conditional specification was implemented. In order to mitigate the risk of selection biases for the application of different respiratory therapies, we conducted the propensity score modeling analysis. A logistic model of receiving invasive support (vs mixed or noninvasive supports or providing no support) was estimated. We then stratified the study population into quintile groups based on the propensity model predicted probability of receiving invasive support, and ran the modeling estimation within each group.
3 | RESULTS
| Study population
Between January 2006 and December 2010, a total of 5086 live born neonates with birth weight between 401 and 1000 g and gestational age <27 weeks were enrolled in the GDB. A total of 1109 infants were excluded from further analysis: 3 for missing data, 73 with congenital heart disease or chromosomal anomalies, and 1033 died within the first day of life. Of the remaining 3977 infants, 1050 (26.4%) died during their initial hospital stay, another 58 (1.5%) infants died after hospital discharge, and 326 (8.2%) infants were lost to follow-up leaving 2543 (63.9%) infants with a neurodevelopmental assessment at 18-22 months (E- Figure S1 ).
Demographics of the study sample are presented in Table 1 .
Infants in whom the primary outcome was assessed were born at median of 25.1 (quartile range 24.4 and 26.0) weeks gestational age and at a median birth weight of 710 g (quartile range 612 g and 820 g).
A total of 51% of the infants were male and 42% were African American. The mothers had a mean age of 27 ± 6 years at delivery, 40%
had private insurance, and 66% had a high school or higher degree.
We assessed whether the infants lost to follow-up differed from those followed. The two groups were similar in maternal insurance status, prenatal care visits, incidence of maternal hypertension, antenatal hemorrhage, and antenatal steroids, or infants' gender, race, gestational age at birth and 1/5 min Apgar scores. However, there were statistically significant differences in birth weight, maternal age, and education between the two groups (Table S1 ).
| Outcomes by respiratory support groups
In this study cohort, the vast majority of infants received some level of 
| Outcomes by total cumulative days of any RS
There is a bimodal distribution of mortality as evaluated by the total cumulative days of any respiratory support in Figure 1 . Mortality rate was >30% in those who received any RS for less than 7 days, decreased to <20% for those received any RS for 14-89 days and then steadily increased to 39% for any RS over 120 days. In addition, Figure 1 also demonstrates an increasing rate of impairment as duration of any respiratory support increases. In these patients, NDI remained steady at 10-15% until after 60 days of support after which NDI increased.
Percentage of infants with CP, blindness, deafness, and decreased cognitive scores <85 and <70 all increased after receiving any RS for more than 60 days. Statistical analysis demonstrated significant increasing trends of the outcome rates with duration of respiratory support (P-value < 0.001) ( Table 3 ). Table 2 shows the number of infants falling into each of the subgroups of RS, and the total duration of receipt of RS by weeks. The primary outcome and its breakdown by components are shown. The overall rate of the primary outcome was 40.9%. In order to determine the relative impact of the mode of RS, we also derived the odds ratios from the estimated logistic regression models comparing each subgroup of RS against each other. A gradient of risk of NDI or death is seen for IRS (Table S2 ).
| Outcomes by RS groups

| Risk factors for NDI at 18-month
In patients who survived to follow-up, the overall rate of NDI was 15.2%. Figure 2 shows that the odds of impairment significantly increased by a factor of 1. Additional factors significantly associated with increased risk of neurodevelopmental impairment are graphically depicted ( Figure 2) and included male gender, severe IVH, PVL, and late onset sepsis. In this cohort of infants, we did not find an independent association between antenatal steroids or postnatal steroids and risk of NDI.
| DISCUSSION
This study evaluated a large, recent multi-center cohort of ELBW infants for the composite outcome of either death or NDI by [18] [19] [20] [21] [22] months. Our data showed that even in an era of non-invasive This table includes infants that received respiratory support for at least one day and survived to follow-up and had NDI information (n = 2538). Each column represents a distinct group of infants. For instance, the column labeled as >1 d contains the statistics for infants that had support for at least 1 days, but less than 7 days; and the column labeled as >7 d contains the statistics for infants that had support for at least 7 days, but less than 14 days. NDI, neurodevelopmental impairment; CP, cerebral palsy. *Mantel-Haenszel Chi-Square Test. Additionally, Cochran-Armitage Trend Tests indicated significant increasing trends of the outcome rates with duration of respiratory support (Left-sided P-value < 0.001). Exact test statistics were calculated due to small sample sizes. **One-way analysis of variance (ANOVA) F test.
FIGURE 2
Risk factors for NDI in survivors at 18-22 months. Multivariate logistic regression model was used to explore risk factors for NDI in survivors. Results are expressed as odds ratios and 95% confidence intervals. * Duration on respiratory support (each additional week of RS), late onset sepsis, male gender, severe IVH, and PVL were associated with NDI after adjustment, P < 0.05. HS, high school; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; and PVL, periventricular leukomalacia the previous data to reflect changes in respiratory support modalities in the contemporary cohort. Although clinicians now use non-invasive modalities more frequently, and the length of invasive support has decreased, we continue to see a similar trend of increasing rate of death or NDI as duration of any respiratory support extends beyond 60 days, regardless of invasive or noninvasive support. There is also a dose-response relationship with higher death or NDI rate in the only I-RS group, followed by the Mixed RS group, and lowest in the only NI-RS group. These data may aid clinicians when discussing short and long-term prognosis with families and participate in decision-making.
Prior data and predictive models have only drawn a link between duration of RS and the outcome of BPD. [22] [23] [24] In addition, those models routinely concentrate on the duration of mechanical ventilation and do not extend predictions out as far as 18-22 months. Finally, many of these instruments are complex mathematical models, rendering them difficult to grasp. An external validation study done by Onland et al 24 demonstrated that most of these models do not perform well enough to be used in routine clinical care. The data as presented as in Figure 1 , may assist clinicians in having these discussions with parents of infants who received prolonged respiratory support.
This study has several strengths and weaknesses. Among the strengths are the large multi-center cohort of ELBW infants, the low lost to follow-up rate (8.2%) , and the standardized data collection. Our data represents care at large academic centers in the United States.
However, outcomes in individual centers may differ from these aggregated results. In addition, without quantitative disease severity scores, it is difficult to separate sicker patients from the ones with milder illness in each RS groups and compare patients with similar disease severity between different RS groups, although the adjusted analyses take account of some of these variations. Further, due to the limitation of the dataset, and the nature of a retrospective study, we were unable to differentiate data miscoding, nor could we control the variations in clinical practice such as indications or thresholds for initiating respiratory support or the selection of different respiratory support methods. We attempted to reduce the risk of selection bias for the application of different respiratory support through propensity score matching, however, the bias cannot be eliminated given there is no alternative to I-RS in the most critically ill infants and all subjects in this study were recruited from large academic centers that potentially could underrepresent infants with milder disease from smaller local NICUs. Although the estimated odds ratios varied by group, the summary odds ratios were close to our original estimates but had wider 95% confidence intervals (Table S3) . A more detailed analysis of the timing of when the different respiratory support occurred might be beneficial to further differentiate the impact of different respiratory support on death and/or NDI. While the primary composite outcome appears to be robust by several analytical steps, we note that Figure 2 for antecedents of NDI alone, suggest a more nuance interpretation. It is possible that while low, the 8% loss to FU may have affected this finding, and reflects attrition bias. To minimize bias of the missing sample, we have adjusted for birth weight and maternal factors including age and education in the primary analysis and performed multiple imputation analysis, which demonstrated that missing data to lost to follow-up did not alter the results (Table S2 [1995] [1996] [1997] [1998] , and the finding of a similar relationship between prolonged respiratory support and NDI is consistent between the two cohorts and supports the findings.
| Summary
In summary, our findings demonstrate that prolonged respiratory support, regardless of whether invasive or non-invasive support, is associated with an increased risk of mortality or neurodevelopmental disability. In addition, there is a dose-dependent increase in the risk of Kendrick (DCC Statistician) had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis.
We are indebted to our medical and nursing colleagues and the infants and their parents who agreed to take part in this study. 
